Results

Total Results: 4,659 records

Showing results for "obesity screening".

4321. Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
      July 08, 2014 - implication of these findings is that antenatal depression should be identified through universal screening … children goes beyond developmental health and can potentially impact lifelong health trajectories (obesity

4322. Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
      July 08, 2014 - implication of these findings is that antenatal depression should be identified through universal screening … children goes beyond developmental health and can potentially impact lifelong health trajectories (obesity

4323. Pathways Community HUB Manual (pdf file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/innovations/CommunityHubManual.pdf
      January 01, 2016 - Obesity, infant mortality, and chronic conditions are current focus areas of the SIM initiative. … with first medical home visit, successful delivery of evidence-based education packages to prevent obesity … As noted earlier, setting such a threshold— such as screening 80 percent of the population for lead exposure—creates

4324. Pathways Community HUB Manual (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/innovations/CommunityHubManual.pdf
      January 01, 2016 - Obesity, infant mortality, and chronic conditions are current focus areas of the SIM initiative. … with first medical home visit, successful delivery of evidence-based education packages to prevent obesity … As noted earlier, setting such a threshold— such as screening 80 percent of the population for lead exposure—creates

4325. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
      June 01, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Increasing age, obesity, injury to or overuse of a joint, and genetics can all contribute to the disease

4326. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
      December 01, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … prevalence has increased during the past two decades, and continued increases are expected with increased obesity

4327. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
      December 05, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Increasing age, obesity, injury to or overuse of a joint, and genetics can all contribute to the disease

4328. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
      December 01, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … prevalence has increased during the past two decades, and continued increases are expected with increased obesity

4329. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
      June 01, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Increasing age, obesity, injury to or overuse of a joint, and genetics can all contribute to the disease

4330. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
      December 05, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Increasing age, obesity, injury to or overuse of a joint, and genetics can all contribute to the disease

4331. Interventions in Primary Care to Promote Breastfeeding: An Evidence Review (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/WYuzSoTB7frsav2gnsP7SR
      January 01, 2010 - Obesity (32, 33) Ever vs. never breastfed Reported in a previous meta-analysis of 7 cross-sectional … Breast-feeding and childhood obesity—a systematic review.

4332. HEALTHCARE COST AND UTILIZATION PROJECT — HCUP (pdf file)
      hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2014.pdf
      January 01, 2014 - admission  CCS 256: Medical examination/evaluation  CCS 257: Other aftercare  CCS 258: Other screening … disorders: (1) comorbidity present, (0) comorbidity not present CM_OBESE AHRQ comorbidity measure - Obesity … Sexually transmitted infections (not HIV or hepatitis) 699 14.16 14.45 2.0 10: Immunizations and screening … examination/evaluation 101 22.77 23.76 4.3 257: Other aftercare 1,889 14.08 14.45 2.6 258: Other screening … 18.68 19.28 3.2 662: Suicide and intentional self-inflicted injury 240 16.67 17.50 5.0 663: Screening

4333. App-D-Surveillance-Report-1-Noninvasive-Nonpharm-Chronic-Pain (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surveillance-report-1-noninvasive-nonpharm-chronic-pain.xlsx
      January 01, 2021 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … 6 months Exclusion: Back surgery in the last 12 months, back pain from systemic conditions, morbid obesity … KL grade 3 : 39% vs. 38% vs. 46% - KL grade 4: 11% vs. 11% vs. 8% Hypertension: 56% vs. 64% vs. 61% Obesity

4334. App-D-Surv-Report-1-Noninvasive-Nonpharma (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma.xlsx
      January 01, 2021 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … 6 months Exclusion: Back surgery in the last 12 months, back pain from systemic conditions, morbid obesity … KL grade 3 : 39% vs. 38% vs. 46% - KL grade 4: 11% vs. 11% vs. 8% Hypertension: 56% vs. 64% vs. 61% Obesity

4335. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
      January 01, 2021 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … 6 months Exclusion: Back surgery in the last 12 months, back pain from systemic conditions, morbid obesity … KL grade 3 : 39% vs. 38% vs. 46% - KL grade 4: 11% vs. 11% vs. 8% Hypertension: 56% vs. 64% vs. 61% Obesity

4336. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
      January 01, 2021 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … 6 months Exclusion: Back surgery in the last 12 months, back pain from systemic conditions, morbid obesity … KL grade 3 : 39% vs. 38% vs. 46% - KL grade 4: 11% vs. 11% vs. 8% Hypertension: 56% vs. 64% vs. 61% Obesity

4337. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
      January 01, 2021 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … 6 months Exclusion: Back surgery in the last 12 months, back pain from systemic conditions, morbid obesity … KL grade 3 : 39% vs. 38% vs. 46% - KL grade 4: 11% vs. 11% vs. 8% Hypertension: 56% vs. 64% vs. 61% Obesity

4338. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
      January 01, 2021 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … 6 months Exclusion: Back surgery in the last 12 months, back pain from systemic conditions, morbid obesity … KL grade 3 : 39% vs. 38% vs. 46% - KL grade 4: 11% vs. 11% vs. 8% Hypertension: 56% vs. 64% vs. 61% Obesity

4339. Building a Team and Process to Reduce CAUTI Risk (April 8, 2015) | Agency for Healthcare Research and Quality
      ce.effectivehealthcare.ahrq.gov/hai/cauti-tools/archived-webinars/building-teamwork-transcript.html
      December 01, 2017 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

4340. Adverse Events Associated With COVID-19 Pharmaceutical Treatments | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/COVID-19-pharmaceutical-treatments/rapid-research
      March 01, 2024 - studies included patients with a number of conditions such as chronic obstructive pulmonary disease, obesity